Eric Matteson, MD
Mayo Clinic College of Medicine and Science
Rochester, Minnesota, United States
Disclosure information not submitted.
Leo Anthony Celi, MD, MSc, MPH
Massachusetts Institute of Technology; Harvard Medical School
CAMBRIDGE, Massachusetts, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Keymanthri Moodley, PhD, MBChB
Stellenbosch University
Rondebosch, South Africa
Disclosure(s): No financial relationships with ineligible companies to disclose
This Global Summit addresses the emergent field of artificial intelligence (AI) and some of its potentials and challenges for global health and the field of rheumatology. Many AI applications are already well developed, such as computer assisted radiograph interpretation, and many more are in use or in development across all aspects of healthcare including clinical service delivery and promotion of population health. Furthermore, AI has been heralded as a vehicle for achieving equity in access to information, services, and resources, in particular for those in underserved areas.
The promise of AI in global rheumatology includes increased access to training opportunities and clinical decision support tools, patient facing tools to promote awareness and earlier access to healthcare, and reduced management variability. It also helps support healthcare policy and facilitate rheumatology research. AI as a means to improve healthcare also means recognizing that challenges such as accessibility, scalability, equity and appropriateness of AI technologies have tradeoffs and risks which vary greatly between high and low resource settings.
Virtual Speaker: Deborah Desir, MD – Yale School of Medicine
Virtual Moderator: Eric Matteson, MD – Mayo Clinic College of Medicine and Science
Virtual Speaker: Keymanthri Moodley, PhD, MBChB – Stellenbosch University
Virtual Speaker: Leo Anthony A. Celi, MD, MSc, MPH – Massachusetts Institute of Technology; Harvard Medical School